i-SENS, Inc.

medical devices

About

i-SENS, Inc. is a global in vitro diagnostics company founded in 2000, specializing in the research, development, and production of advanced diagnostic products. The company utilizes biosensor and electrochemical technologies to create innovative medical devices, including blood glucose monitors, electrolyte analyzers, blood gas analyzers, and immunochemistry analyzers. Many of these products are designed for point-of-care use and can utilize whole blood. The company is well-known for its blood glucose monitoring devices, which are recognized for their intuitive design and accuracy in over 110 countries, including Korea, the United States, and Europe. In 2023, i-SENS launched CareSens Air, Korea's first continuous glucose monitoring system, enhancing its offerings in blood glucose management. With plans to expand its global presence, starting in Europe in 2024, i-SENS continues to invest in research and development to maintain its leadership in the diagnostic market and contribute to human health through advanced technology.

Technologies

Outlook Amazon AWS Google Maps Bootstrap Framework YouTube Nginx Google Play Mobile Friendly Google Font API Google Tag Manager WordPress.org

Keywords

ivd diabetes blood glucose monitoring system point of care bgms poc ketone invitro diagnostics diagnostics medical equipment manufacturing blood glucose management esg management b2c continuous glucose monitoring system medical devices medical equipment and supplies manufacturing in vitro diagnostic system remote patient monitoring medical device manufacturing patient-centered care bio-sensor technology healthcare equipment & supplies e-commerce d2c services iso 15197:2013 compliance sustainable supply chain global market expansion government in vitro diagnostics

Location

Seoul, Seoul, South Korea, 137-070

Related Companies

Companies in the same industry